… One of the barriers in developing efficacious salvage … CIT combination reported in NSCLC
studies [ 12 , 18 ], we have employed the addition of cytotoxic chemotherapy to ongoing PD-1 …

… into the form of lnHR and standard error of lnHR (selnHR). As … of 185 records were reviewed
for full-text assessment after … that the combination of Pembro/Atez and Chemo are preferred …

… the efficacy of combined therapy of PD-1 inhibitor with … A total of 50 (90.9%) patients in this
study have failed after … plus beva and 75% (3/4) in anti-PD-1 plus chemo/beva. The DCR was …

… After rigorous screening, 5 studies involving a total of 3,163 … PD-1 inhibitors plus
chemotherapy combinations, tori-chemo … However, we failed to find similar results in our analysis. …

… surgery, radiotherapy and chemotherapy [Citation4]. However… KEYNOTE-021 was first
conducted to evaluate the efficacy of … undergone systemic treatment failure. Toripalimab displayed …

… Tim-3 (+) PD-1 (+) TILs is a severe failure phenotype, which does not proliferate to produce
… with chemotherapy alone (93,94). Anti-PD-1 therapy enhances the efficacy of radiotherapy in …

… efficacy when used in combination with immunotherapy in lung cancer. Whether chemotherapy
after checkpoint inhibitor failure … the efficacy and safety of various chemotherapy regimes …

… As the selection of second-line salvage therapy after failure of PD1 may impact survival,
Kaplan… Four studies have tested the efficacy of PD1 plus radiotherapy, including a study recently …

… results in terms of both efficacy and toxicity [4,15]. KEYNOTE-… half of patients with MBM fail
to respond to systemic therapy. … -week interval to radiotherapy were analyzed [49]. The best …

… in 2018 evaluating the efficacy of the combination of immune-… to chemotherapy alone;
however, two further phase 3 studies … with NSCLC failed to confirm the original phase 2 findings …